drugset / Trial / NCT00427687
Study Evaluating AGG-523 in Subjects With Osteoarthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the effect of AGG-523 administration on biomarkers related to osteoarthritis. Safety and tolerability of AGG-523 will also be assessed.
Timeline
- Start
- 2007-02
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AGG-523 | Small molecule | — | Oral |